EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Molecular Pharmacology of Selective Na V 1.6 and Dual Na V 1.6/Na V 1.2 Channel Inhibitors that Suppress Excitatory Neuronal Activity Ex Vivo

Samuel J Goodchild iD, Noah Gregory Shuart, Aaron D Williams, Wenlei Ye, R Ryley Parrish, Maegan Soriano, Samrat Thouta, Janette Mezeyova, Matthew Waldbrook, Richard Dean, Thilo Focken iD, Mohammad-Reza Ghovanloo iD und 5 weitere

ACS Chemical Neuroscience · 20.03.2024 · 15 (6) · 1169-1184

DOI: 10.1021/acschemneuro.3c00757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Chemical Neuroscience, online erschienen am 15.02.2024. Verfasst von Samuel J Goodchild und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Molecular Biology, Xenon Pharmaceuticals, Burnaby, BC V5G 4W8, Canada. Hauptthemen laut MEDLINE: Voltage-Gated Sodium Channels, Epilepsy. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, Mitacs, Xenon Pharmaceuticals, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Voltage-Gated Sodium ChannelsEpilepsyHumansNeuronsBrainSeizuresAction Potentials

Stichwörter der Autor:innen

antiseizure medicationbiophysicsepilepsypharmacologyprecision medicinesodium channel

Substanzen

Voltage-Gated Sodium Channels

Autor:innen und Institutionen

  • Department of Cellular and Molecular Biology, Xenon Pharmaceuticals, Burnaby, BC V5G 4W8, Canada.
  • Neurocrine Biosciences, San Diego, California 92130, United States.
  • Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC V5A 1S6, Canada.
  • Department of Neurology, Yale University, New Haven, Connecticut 06519, United States.

ORCID-Profile: Samuel J Goodchild, Thilo Focken, Mohammad-Reza Ghovanloo

Förderung

  • Natural Sciences and Engineering Research Council of Canada
  • Mitacs
  • Xenon Pharmaceuticals, Inc.

Zitieren

APA

Goodchild, S. J., Shuart, N. G., Williams, A. D., Ye, W., Parrish, R. R., Soriano, M., Thouta, S., Mezeyova, J., Waldbrook, M., Dean, R., Focken, T., Ghovanloo, M. R., Ruben, P. C., Scott, F., Cohen, C. J., Empfield, J., & Johnson, J. P. (2024). Molecular Pharmacology of Selective Na V 1.6 and Dual Na V 1.6/Na V 1.2 Channel Inhibitors that Suppress Excitatory Neuronal Activity Ex Vivo. ACS Chemical Neuroscience, 15(6), 1169-1184. https://doi.org/10.1021/acschemneuro.3c00757

Vancouver

Goodchild SJ, Shuart NG, Williams AD, Ye W, Parrish RR, Soriano M, et al. Molecular Pharmacology of Selective Na V 1.6 and Dual Na V 1.6/Na V 1.2 Channel Inhibitors that Suppress Excitatory Neuronal Activity Ex Vivo. ACS Chemical Neuroscience. 2024;15(6):1169-1184. doi:10.1021/acschemneuro.3c00757

BibTeX
@article{Goodchild2024,
  author = {Goodchild, Samuel J and Shuart, Noah Gregory and Williams, Aaron D and Ye, Wenlei and Parrish, R Ryley and Soriano, Maegan and Thouta, Samrat and Mezeyova, Janette and Waldbrook, Matthew and Dean, Richard and Focken, Thilo and Ghovanloo, Mohammad-Reza and Ruben, Peter C and Scott, Fiona and Cohen, Charles J and Empfield, James and Johnson, J P},
  title = {Molecular Pharmacology of Selective Na V 1.6 and Dual Na V 1.6/Na V 1.2 Channel Inhibitors that Suppress Excitatory Neuronal Activity Ex Vivo},
  journal = {ACS Chemical Neuroscience},
  year = {2024},
  volume = {15},
  number = {6},
  pages = {1169--1184},
  doi = {10.1021/acschemneuro.3c00757}
}
Kostenlos starten →